Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5185249

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COC(=O)c1ccc(CNC[C@@H](O)CN2C[C@H]3CCCC[C@H]3C[C@H]2C(=O)NC(C)(C)C)cc1

Basic Information

ChEMBL ID CHEMBL5185249
Phase Preclinical
Structure Type MOL
InChI Key CJBVIOFPUXUSKT-AFXVXQJMSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

459.6
MW (Da)
2.72
ALogP
6
HBA
3
HBD
90.9
PSA (Ų)
0.52
QED
0
Ro5 Violations
8
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C26H41N3O4
MW 459.63
Aromatic Rings 1
Heavy Atoms 33
NP-Likeness -0.39

Activity Summary

IC50 1 meas. best 5.69

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.69 5.69 2060.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 2060.0 nM 5.69 Inhibition of glycoprotein in luciferase expressing pseudotyped Ebola virus infe... 35872393

Literature References

PubMed DOI Target Context # Activities
35872393 10.1016/j.ejmech.2022.114608 Unchecked 2
35872393 10.1016/j.ejmech.2022.114608 Huh-7 1
35872393 10.1016/j.ejmech.2022.114608 ADMET 1

Data from ChEMBL 36 via Core Engine